Bharat Parenterals profitability ratios

Profitability Growth Credit Liquidity Working capital Dividend yield DuPont CAGR

Per cent unless marked ×

Tap a line for its trend	FY23Mar 2023	FY22Mar 2022

Returns
	13.6%	12.8%
	9.3%	9.8%
	6.1%	9.9%
Margins
	9.8%	13.3%
	7.1%	10.1%
	−100.0%	—
	14.8%	13.4%
	11.2%	10.1%
	−5.3%	—
Additional
	24.4%	25.9%
	13.6%	12.8%

Open the chart

From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.

alphave

BPLPHARMA₹1,912.90

Bharat Parenterals Limited

· Pharma & Health

₹ CrorePeersJENBURPH KPL MAKERSL NOVARTIND PARNAXLAB SGRL SHUKRAPHAR SUNLOCMcap ₹1,105 Cr

Profitability Growth Credit Liquidity Working Capital Yield Analysis DuPont

Ratios — % unless marked × 12 Months Ending	FY22 31/03/2022	FY23 31/03/2023
Returns
Return on Common Equity	12.82	13.63
Return on Assets	9.77	9.25
Return on Invested Capital	9.88	6.13
Margins
EBITDA Margin	13.28	9.80
Operating Margin	10.13	7.12
Incremental Operating Margin	—	-100.03
Pretax Margin	13.38	14.76
Net Income Margin	10.05	11.16
FCF Margin	—	-5.30
Additional
Effective Tax Rate	25.93	24.35
Sustainable Growth Rate	12.82	13.63

No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY23 · StandaloneFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 85%.